For Healthcare Professionals

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

clipboard-pencil

About the study

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of INCB099318 in select solid tumors.
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.

Study’s details


Age (in years)

18 - 200

Phase

Phase 1

Participants needed

140

Est. Completion Date

Jun 2024

Treatment type

Interventional


Sponsor

Incyte Corporation

ClinicalTrials.gov identifier

NCT04272034

Study number

INCB 99318-122

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.